Precigen, Inc is a dedicated discovery and clinical stage biopharmaceutical company based in Germantown, MD. Specializing in gene and cell therapies, Precigen focuses on immuno-oncology, autoimmune disorders, and infectious diseases, utilizing precision technology to target urgent and intractable medical conditions.
Operating as an innovation engine, Precigen progresses a pipeline of unique therapies towards clinical proof of concept and commercialization. With a disciplined design approach and advanced bioengineering technologies, the company aims to deliver potent, on-target gene and cellular therapies with improved safety and efficacy in the fight against cancer.
Generated from the website